Caffeine-Induced Anxiety Disorder
Caffeine-induced anxiety disorder is a subclass of the DSM-5 diagnosis of substance/medication-induced anxiety disorder.
Cluster Number:
Wiki Number: W029
Diagnosis: Caffeine-Induced Anxiety Disorder
US Patients:
World Patients:
Sex Ratio:
Age Onset:
Brain Area: passes the blood-brain barrier; affects hippocampus, cerebral cortex, thalamus
Symptoms: 2+ cups of coffee develops effect
Progression: immediately affects anxiety-but not long-term
Causes:
Medications: anti-anxiety medications
Therapies: None provided.
Youtube Video: Quit Coffee – No headaches
Amazon or Library Book: Caffeine-Induced Anxiety Disorder
Click the book to link or order from Amazon.
Support Group: caffeineaddictsanonymous; On-line
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Caffeine consumption of medical students in Korea: amount and symptoms based on a 2023 surveyby Seong Woo Choi on September 9, 2024
CONCLUSION: Caffeinated beverage consumption was routine among current medical students, with 20% consuming more than the recommended daily amount. Most students experienced at least one caffeine-induced symptom, with two symptoms in half, suggesting the need for policy measures and warnings about caffeine-containing foods.
- Caffeine-Induced Psychosis: A Case Report and Review of Literatureby Dylan Mannix on September 6, 2024
A 51-year-old female, with no previous history of psychosis, presented to the Emergency Department with an acute psychotic episode in the context of excess caffeine consumption. Caffeine is an adenosine antagonist. An antagonist of adenosine can lead to the release of dopamine into the synaptic cleft, which can induce psychotic symptoms in vulnerable individuals. The patient had consumed caffeine in the form of up to eight energy drinks daily. She experienced persecutory delusions alongside...
- JM-20 potently prevents the onset of caffeine-induced anxiogenic phenotypes in zebrafish (Danio rerio)by Matheus Mülling Dos Santos on January 18, 2024
Anxiety is among the most prevalent mental disorders present in the general population. Benzodiazepines are the most commonly prescribed drugs for the treatment of anxiety. Using zebrafish as a model organism, we investigated the anxiolytic activity of JM-20, a novel hybrid molecule with a 1,5-benzodiazepine ring fused to a dihydropyridine moiety. Firstly, we carried out some assays to analyze the possible toxicity mediated by JM-20. For this, zebrafish were exposed to different JM-20...
- Inversely Regulated Inflammation-Related Processes Mediate Anxiety-Obesity Links in Zebrafish Larvae and Adultsby Hila Yehuda on July 14, 2023
Anxiety and metabolic impairments are often inter-related, but the underlying mechanisms are unknown. To seek RNAs involved in the anxiety disorder-metabolic disorder link, we subjected zebrafish larvae to caffeine-induced anxiety or high-fat diet (HFD)-induced obesity followed by RNA sequencing and analyses. Notably, differentially expressed (DE) transcripts in these larval models and an adult zebrafish caffeine-induced anxiety model, as well as the transcript profiles of inherently anxious...